A |
Back to top |
852A
|
|
|
|
|
|
9025
|
|
A286982
|
|
|
|
|
|
6592
|
A 286982,
A-286982
|
A438079
|
|
|
|
|
|
4118
|
A 438079,
A-438079
|
abatacept
|
|
|
|
|
|
6891
|
BMS-188667,
CTLA4-IgG4m,
Orencia®,
RG-1046,
RG-2077
|
abediterol
|
|
|
|
|
|
9326
|
LAS-100977
|
ABT-737
|
|
|
|
|
|
8320
|
ABT 737,
ABT737,
compound 2 [PMID 17256834]
|
AC430
|
|
|
|
|
|
9177
|
AC-430
|
acalabrutinib
|
|
|
|
|
|
8912
|
ACP-196,
Calquence®,
Example 6 [US20140155385 A1]
|
ACT-389949
|
|
|
|
|
|
9511
|
|
ACTH
{Sp: Human}
|
|
|
|
|
|
3633
|
Acthar®,
adrenocorticotropic hormone (1-39),
corticotropin
|
acumapimod
|
|
|
|
|
|
9203
|
BCT 197,
BCT-197,
BCT197,
compound A [WO2013139809]
|
adalimumab
|
|
|
|
|
|
4860
|
D2E7,
FKB327,
Humira®
|
adavivint
|
|
|
|
|
|
9620
|
SM0-4690,
SM04690
|
(-)-adrenaline
|
|
|
|
|
|
479
|
adrenalin,
Auvi-Q®,
Epipen®,
l-adrenaline,
L-epinephrine,
levoepinephrine
|
AF12198
|
|
|
|
|
|
4861
|
AF 12198,
AF-12198
|
AH6809
|
|
|
|
|
|
1896
|
AH 6809,
AH-6809
|
ajulemic acid
|
|
|
|
|
|
9772
|
CPL-7075,
CPL7075,
CT-3,
IP-751,
IP751,
lenabasum (proposed INN)
|
AL-78898A
|
|
|
|
|
|
9219
|
4(1MeW),
POT-4
|
alcaftadine
|
|
|
|
|
|
7587
|
Lastacaft®,
R-89674
|
alefacept
|
|
|
|
|
|
6787
|
Amevive®,
BG 9273,
BG 9712,
BG-9273,
BG-9712,
Lfa3Tip
|
alemtuzumab
|
|
|
|
|
|
6770
|
campath 1H,
Campath®,
campath-1H,
Lemtrada®
|
alimemazine
|
|
|
|
|
|
7237
|
Nedeltran®,
trimeprazine
|
alpelisib
|
|
|
|
|
|
7955
|
BYL 719,
BYL-719,
NVP-BYL719
|
3 alpha-aminocholestane
|
|
|
|
|
|
9564
|
3AC,
3 α-aminocholestane
|
ALT-803
|
|
|
|
|
|
9615
|
|
alvelestat
|
|
|
|
|
|
6476
|
AZD 9668,
AZD-9668,
AZD9668,
KB-105160
|
amcinonide
|
|
|
|
|
|
7060
|
CL-34699,
Cyclocort®
|
amelubant
|
|
|
|
|
|
8463
|
BIIL 284,
BIIL-284
|
AMG319
|
|
|
|
|
|
8917
|
AMG 319,
AMG-319
|
AMG820
|
|
|
|
|
|
9106
|
|
amiselimod
|
|
|
|
|
|
9319
|
Example 1 [US20090137530],
MT-1303,
MT1303
|
amiselimod phosphate
|
|
|
|
|
|
9491
|
amiselimod-P
|
amlexanox
|
|
|
|
|
|
7113
|
AA-673,
Amlexanox®,
Aphthasol®,
CHX-3673
|
anakinra
|
|
|
|
|
|
6972
|
antril,
Kineret®
|
ancriviroc
|
|
|
|
|
|
804
|
SCH 351125,
SCH-351125,
SCH-C
|
andecaliximab
|
|
|
|
|
|
9510
|
GS-5745
|
andrographolide
|
|
|
|
|
|
9675
|
|
anifrolumab
|
|
|
|
|
|
8258
|
MDX-1333,
MEDI-546
|
apafant
|
|
|
|
|
|
1860
|
WEB 2086 BS,
WEB-2086
|
apremilast
|
|
|
|
|
|
7372
|
CC-10004,
Otezla®
|
APRIL
{Sp: Human}
|
|
|
|
|
|
5068
|
A proliferation-inducing ligand,
TALL2,
TNF- and APOL-related leukocyte expressed ligand 2,
TNF-related death ligand 1,
TRDL-1,
ZTNF2
|
arformoterol
|
|
|
|
|
|
7479
|
Brovana®,
YM-08316
|
ARGX-110
|
|
|
|
|
|
9778
|
ARGX110,
clone 41D12,
cusatuzumab (proposed INN)
|
(R)-ARN2508
|
|
|
|
|
|
9000
|
compound (-)-10r [PMID: 26774927],
example 19 [WO2014023643]
|
(S)-ARN2508
|
|
|
|
|
|
8999
|
compound (+)-10r [PMID: 26774927],
example 20 [WO2014023643]
|
ARRY-382
|
|
|
|
|
|
9108
|
ARRY 382,
ARRY382
|
AS101
|
|
|
|
|
|
437
|
ammonium tri-chloro(dioxoethylene-O,O'-)tellurate,
AS 101,
AS-101
|
asimadoline
|
|
|
|
|
|
9279
|
EMD 61 753,
EMD 61753,
EMD-61753
|
asivatrep
|
|
|
|
|
|
9621
|
Example 230 [US7858621],
PAC-14028
|
ASP4058
|
|
|
|
|
|
9569
|
ASP-4058
|
aspirin
|
|
|
|
|
|
4139
|
Acetophen®,
acetylsalicylic acid,
Aspirin®
|
AT38
|
|
|
|
|
|
9020
|
[3-(aminocarbonyl)furoxan-4-yl]methyl salicylate
|
atacicept
|
|
|
|
|
|
9517
|
TACI-Fc,
TACI-Ig
|
ATB-346
|
|
|
|
|
|
9534
|
ATB 346
|
atezolizumab
|
|
|
|
|
|
7990
|
MPDL3280A,
Tecentriq®
|
atracurium
|
|
|
|
|
|
9537
|
atracurium besilate,
atracurium dibesylate,
BW 33A,
Tracrium®
|
auranofin
|
|
|
|
|
|
6306
|
Ridaura®,
SK&F-39162,
SK-39162
|
avacopan
|
|
|
|
|
|
9450
|
CCX-168,
CCX168
|
AVE 0991
|
|
|
|
|
|
5579
|
AVE-0991,
AVE0991
|
avelumab
|
|
|
|
|
|
8735
|
Bavencio®,
MSB-0010718C,
MSB0010718C
|
AZ13102909
|
|
|
|
|
|
9577
|
AZ909
|
AZ3451
|
|
|
|
|
|
9560
|
|
AZ7188
|
|
|
|
|
|
9586
|
|
AZ8838
|
|
|
|
|
|
9585
|
|
azacitidine
|
|
|
|
|
|
6796
|
5-AZAC,
5-azacytidine,
ladakamycin,
U-18496,
Vidaza®
|
azapro-3
|
|
|
|
|
|
9221
|
|
azatadine
|
|
|
|
|
|
7119
|
Optimine®,
SCH-10649
|
azathioprine
|
|
|
|
|
|
7120
|
Azasan®,
BW-57-322,
Imuran®
|
AZD1236
|
|
|
|
|
|
7844
|
AZD 1236,
AZD-1236
|
AZD1678
|
|
|
|
|
|
9679
|
AZD-1678,
compound 49 [PMID: 28947948]
|
AZD1981
|
|
|
|
|
|
7680
|
AZD 1981,
AZD-1981
|
AZD2098
|
|
|
|
|
|
9678
|
AZD-2098,
compound 47 [PMID: 28947948]
|
AZD2423
|
|
|
|
|
|
7825
|
AZD 2423,
AZD-2423
|
AZD5069
|
|
|
|
|
|
8948
|
|
AZD5672
|
|
|
|
|
|
7686
|
AZD 5672,
AZD-5672
|
AZD6605
|
|
|
|
|
|
7823
|
AZ 11920155,
AZ-11920155,
AZ11920155,
AZD 6605,
AZD-6605
|
AZD6703
|
|
|
|
|
|
7687
|
AZ 12012199,
AZ-12012199,
AZ12012199,
AZD 6703,
AZD-6703
|
AZD7594
|
|
|
|
|
|
9325
|
AZ13189620,
compound 15m [PMID: 28937774]
|
AZD7986
|
|
|
|
|
|
9412
|
compound 30
|
AZD8848
|
|
|
|
|
|
9256
|
DSP-3025
|
AZD9056
|
|
|
|
|
|
7826
|
AZD 9056,
AZD-9056
|
AZD9567
|
|
|
|
|
|
9812
|
compound 15 [PMID: 29424542],
example 1 [WO2016046260A1]
|
azelaic acid
|
|
|
|
|
|
7484
|
Azelex®,
Finacea®,
ZK-62498
|
AZ11657312 (salt free)
|
|
|
|
|
|
7722
|
|
|
B |
Back to top |
bafetinib
|
|
|
|
|
|
7906
|
INNO-406,
Lyn-IN-1,
NS-187
|
BAFF
{Sp: Human}
|
|
|
|
|
|
5069
|
B cell-activating factor,
CD257 antigen,
dendritic cell-derived TNF-like molecule
|
bardoxolone
|
|
|
|
|
|
2717
|
CDDO,
RTA-401
|
baricitinib
|
|
|
|
|
|
7792
|
INCB-028050,
LY-3009104,
LY3009104,
Olumiant®
|
basiliximab
|
|
|
|
|
|
6879
|
CHI-621,
L04AC02,
SDZ-CHI-621,
Simulect®
|
BAYu9773
|
|
|
|
|
|
3381
|
BAY u9773,
BAY-u 9773
|
beclometasone
|
|
|
|
|
|
7059
|
beclomethasone,
SCH-18020W
|
beclometasone dipropionate
|
|
|
|
|
|
5894
|
beclomethasone dipropionate,
Beconase®,
Qnasl®,
Vancenase®
|
begelomab
|
|
|
|
|
|
8691
|
Begendina&rg; (proprietary name),
BT 5/9,
SAND 26
|
belatacept
|
|
|
|
|
|
6892
|
BMS-224818,
LEA29Y,
Nulojix®
|
belimumab
|
|
|
|
|
|
6887
|
Benlysta®,
hBlySmAb-1.1,
lymphostat-B
|
belnacasan
|
|
|
|
|
|
9035
|
VX-765
|
benralizumab
|
|
|
|
|
|
7674
|
BIW-8405,
Fasenra®,
KHK4563,
MEDI-563
|
benzodrocortisone
|
|
|
|
|
|
9731
|
compound 1 [WO2013071010],
hydrocortisone 17-benzoate
|
3beta-Hydroxy-20(29)-lupene
|
|
|
|
|
|
9028
|
Fagarasterol,
Lupeol
|
betamethasone
|
|
|
|
|
|
7061
|
SCH-4831
|
BGB-3111
|
|
|
|
|
|
9591
|
|
BGB-A317
|
|
|
|
|
|
9592
|
|
BI-1935
|
|
|
|
|
|
9717
|
BI 1935,
example 3 [WO2007067836]
|
BI-1950
|
|
|
|
|
|
9719
|
|
BI-2545
|
|
|
|
|
|
9791
|
BI2545,
compound 19 [PMID: 29259743]
|
BI605906
|
|
|
|
|
|
9357
|
3-Amino-4-(1,1-difluoro- propyl)-6-(4-methanesulfonyl- piperidin-1-yl)-thieno[2,3- b]pyridine-2-carboxylic acid amide,
compound 115 [US20070293533]
|
BI 653048
|
|
|
|
|
|
9715
|
(R)-39,
BI 653048 BS H3PO4,
BI-653048,
BI653048
|
BI 665915
|
|
|
|
|
|
9716
|
BI-665915,
compound 69 [PMID: 25671290]
|
BI-6901
|
|
|
|
|
|
9714
|
BI 6901,
BI 6901,
BI6901,
eut-22
|
bihelical apoA-I mimetic peptide 5A
|
|
|
|
|
|
9183
|
5A peptide
|
bimekizumab
|
|
|
|
|
|
9411
|
CA028_0496,
CDP4940,
gL7gH9,
UCB-4940,
UCB4940,
Zu-G1
|
bimosiamose
|
|
|
|
|
|
9049
|
compound 15e [PMID: 9544210],
TBC 1269,
TBC-1269,
TBC1269
|
BIRT 377
|
|
|
|
|
|
9720
|
BIRT-377
|
blinatumomab
|
|
|
|
|
|
7384
|
Blincyto®,
bscCD19xCD3,
MEDI-538,
MT-103,
MT103
|
blisibimod
|
|
|
|
|
|
9518
|
A-623,
AGP3 peptibody,
AMG 623,
Fc-Agp-3
|
BLZ945
|
|
|
|
|
|
8250
|
BLZ 945,
BLZ-945
|
BML-281
|
|
|
|
|
|
9664
|
compound 3 [PMID: 18642892]
|
BMS-1166
|
|
|
|
|
|
9608
|
compound 2c [PMID: 28613862]
|
BMS-202
|
|
|
|
|
|
9607
|
compound 1c [PMID: 28613862],
PD1-PDL1 inhibitor 2
|
BMS-345541
|
|
|
|
|
|
5669
|
BMS 345541,
BMS345541
|
BMS-561392
|
|
|
|
|
|
6509
|
BMS 561392,
BMS561392,
DPC-333
|
BMS-582949
|
|
|
|
|
|
7838
|
BMS 582949,
BMS582949,
PS 540446,
PS-540446,
PS540446
|
BMS-681
|
|
|
|
|
|
9430
|
compound 13d [PMID: 25893046]
|
BMS-817399
|
|
|
|
|
|
9497
|
compound 29 [PMID: 25101488]
|
BMS-986016
|
|
|
|
|
|
9536
|
ONO-4482
|
BMS-986205
|
|
|
|
|
|
9707
|
BMS986205
|
bosutinib
|
|
|
|
|
|
5710
|
Bosulif®,
SK 606,
SK-606,
SKI 606
|
brazikumab
|
|
|
|
|
|
9293
|
AMG 139,
AMG-139,
MEDI2070
|
brentuximab vedotin
|
|
|
|
|
|
6772
|
Adcetris®,
anti-CD30 ADC SGN-35,
SGN 35
|
briakinumab
|
|
|
|
|
|
9213
|
ABT-874,
J-695,
J695,
Ozespa
|
brimapitide
|
|
|
|
|
|
9101
|
AM-111,
D-JNKI-1,
XG-102
|
brimonidine
|
|
|
|
|
|
520
|
Alphagan®,
Lumify®,
Mirvaso®,
UK14,304,
UK14304
|
BRL-15572
|
|
|
|
|
|
10
|
BRL 15572,
BRL-15,572,
BRL15572
|
brodalumab
|
|
|
|
|
|
7540
|
AMG-827,
AMG827,
Kyntheum®,
Lumicef®,
Siliq®
|
bromfenac
|
|
|
|
|
|
7131
|
AHR-10282B,
Bromday®,
Prolensa®,
Xibrom®
|
BTP2
|
|
|
|
|
|
2438
|
YM-58483
|
budesonide
|
|
|
|
|
|
7434
|
Entocort®,
Pulmicort®,
S-1320,
Uceris®
|
BX 471
|
|
|
|
|
|
767
|
BX-471,
BX-741
|
BX-795
|
|
|
|
|
|
8006
|
BX 795,
BX795
|
|
C |
Back to top |
C108297
|
|
|
|
|
|
9180
|
Compound 52 [PMID:18226897]
|
C391
|
|
|
|
|
|
9570
|
compound 5 [PMID: 27994760]
|
C646
|
|
|
|
|
|
7004
|
|
C5a
{Sp: Human}
|
|
|
|
|
|
573
|
C5a anaphylatoxin,
complement component C5a,
human complement protein
|
cabiralizumab
|
|
|
|
|
|
9107
|
BMS-986227,
FPA-008,
FPA008
|
camrelizumab
|
|
|
|
|
|
9758
|
INCSHR1210,
SHR-1210
|
canakinumab
|
|
|
|
|
|
6773
|
ACZ 885,
ACZ885,
Ilaris®
|
carprofen
|
|
|
|
|
|
7141
|
Ro-205720000
|
CBS-3595
|
|
|
|
|
|
9610
|
|
CC-885
|
|
|
|
|
|
9224
|
|
CCL1
{Sp: Human}
|
|
|
|
|
|
812
|
I309,
TCA-3
|
CCL11
{Sp: Human}
|
|
|
|
|
|
769
|
eotaxin
|
CCL13
{Sp: Human}
|
|
|
|
|
|
770
|
monocyte chemotactic protein-4
|
CCL14
{Sp: Human}
|
|
|
|
|
|
753
|
CCL14a,
CKβ1,
haemofiltrate CC chemokine 1 (HCC-1),
HCC-1(1-74)
|
CCL15
{Sp: Human}
|
|
|
|
|
|
754
|
Lkn-1 [Leukotactin-1],
macrophage inflammatory protein-1δ,
MIP-1δ
|
CCL16
{Sp: Human}
|
|
|
|
|
|
1272
|
|
CCL17
{Sp: Human}
|
|
|
|
|
|
797
|
TARC,
thymus- and activation-regulated chemokine
|
CCL18
{Sp: Human}
|
|
|
|
|
|
4382
|
macrophage inflammatory protein 4,
small-inducible cytokine A18
|
CCL19
{Sp: Human}
|
|
|
|
|
|
810
|
β-chemokine exodus-3,
ck β-11,
ckβ11,
MIP-3β
|
CCL2
{Sp: Human}
|
|
|
|
|
|
771
|
|
CCL20
{Sp: Human}
|
|
|
|
|
|
808
|
LARC,
liver and activation-regulated chemokine,
macrophage inflammatory protein-3α,
MIP-3α
|
CCL21
{Sp: Human}
|
|
|
|
|
|
811
|
ckβ9,
TCA-4
|
CCL22
{Sp: Human}
|
|
|
|
|
|
798
|
dc/β-ck,
macrophage-derived chemokine,
STCP1
|
CCL23
{Sp: Human}
|
|
|
|
|
|
755
|
ckβ8-1,
myeloid progenitor inhibitor factor-1
|
CCL24
{Sp: Human}
|
|
|
|
|
|
775
|
eotaxin-2
|
CCL25
{Sp: Human}
|
|
|
|
|
|
817
|
|
CCL26
{Sp: Human}
|
|
|
|
|
|
776
|
MIP-4α,
PTEC
|
CCL27
{Sp: Human}
|
|
|
|
|
|
3646
|
|
CCL28
{Sp: Human}
|
|
|
|
|
|
3649
|
|
CCL3
{Sp: Human}
|
|
|
|
|
|
756
|
macrophage inflammatory protein-1α,
MIP-1α
|
CCL4
{Sp: Human}
|
|
|
|
|
|
757
|
HC21,
macrophage inflammatory protein-1β,
MIP-1β
|
CCL5
{Sp: Human}
|
|
|
|
|
|
758
|
eosinophil chemotactic cytokine [EoCP],
regulated upon activation normal T cell expressed and secreted (RANTES)
|
CCL7
{Sp: Human}
|
|
|
|
|
|
759
|
|
CCL8
{Sp: Human}
|
|
|
|
|
|
772
|
monocyte chemotactic protein-2
|
CCL1
{Sp: Mouse}
|
|
|
|
|
|
4404
|
|
CCL11
{Sp: Mouse}
|
|
|
|
|
|
787
|
murine eotaxin
|
CCL12
{Sp: Mouse}
|
|
|
|
|
|
4435
|
|
CCL19
{Sp: Mouse}
|
|
|
|
|
|
4417
|
|
CCL2
{Sp: Mouse}
|
|
|
|
|
|
4406
|
|
CCL20
{Sp: Mouse}
|
|
|
|
|
|
4418
|
|
CCL22
{Sp: Mouse}
|
|
|
|
|
|
4420
|
|
CCL24
{Sp: Mouse}
|
|
|
|
|
|
4421
|
|
CCL25
{Sp: Mouse}
|
|
|
|
|
|
4422
|
|
CCL27
{Sp: Mouse}
|
|
|
|
|
|
4462
|
|
CCL28
{Sp: Mouse}
|
|
|
|
|
|
4463
|
|
CCL3
{Sp: Mouse}
|
|
|
|
|
|
4408
|
|
CCL4
{Sp: Mouse}
|
|
|
|
|
|
4410
|
|
CCL7
{Sp: Mouse}
|
|
|
|
|
|
4413
|
|
CCL8
{Sp: Mouse}
|
|
|
|
|
|
4415
|
|
CCL9
{Sp: Mouse}
|
|
|
|
|
|
4434
|
|
CCL5
{Sp: Mouse, Rat}
|
|
|
|
|
|
4412
|
|
CCL11
{Sp: Rat}
|
|
|
|
|
|
4416
|
|
CCL2
{Sp: Rat}
|
|
|
|
|
|
4407
|
|
CCL20
{Sp: Rat}
|
|
|
|
|
|
4419
|
|
CCL3
{Sp: Rat}
|
|
|
|
|
|
4409
|
|
CCL4
{Sp: Rat}
|
|
|
|
|
|
4411
|
|
CCL7
{Sp: Rat}
|
|
|
|
|
|
4414
|
|
Ccl21a
{Sp: Mouse}
|
|
|
|
|
|
8651
|
6Ckine-Ser,
Exodus-2
|
Ccl21b
{Sp: Mouse}
|
|
|
|
|
|
8652
|
6Ckine-Leu,
Exodus-2
|
CCR2-RA-[R]
|
|
|
|
|
|
9431
|
analog 49 (Dasse et al., 2007)
|
CDP840
|
|
|
|
|
|
9330
|
CDP 840,
CDP-840
|
celecoxib
|
|
|
|
|
|
2892
|
Celecox®,
Onsenal®
|
cenerimod
|
|
|
|
|
|
9824
|
ACT-334441
|
cerdulatinib
|
|
|
|
|
|
8957
|
PRT 062070,
PRT-062070,
PRT-2070,
PRT062070
|
certolizumab pegol
|
|
|
|
|
|
6774
|
CDP870,
Cimzia®,
PHA 738144
|
cetirizine
|
|
|
|
|
|
1222
|
Reactine®,
Zyrtec®
|
CFZ533
|
|
|
|
|
|
9802
|
CFZ-533,
iscalimab (proposed INN),
NVP-CFZ533,
OM11-62MF
|
CGI1746
|
|
|
|
|
|
8066
|
CGI 1746,
CGI-1746
|
CGI560
|
|
|
|
|
|
9264
|
CGI-560
|
CHMFL-BTK-11
|
|
|
|
|
|
9516
|
|
cibinetide
|
|
|
|
|
|
9677
|
ARA 290,
ARA-290,
PH-BSP,
PHBSP
|
cicaprost
|
|
|
|
|
|
1917
|
ZK 96480,
ZK-96480
|
ciclesonide
|
|
|
|
|
|
7469
|
Alvesco®,
Omnaris®,
RPR-251526
|
cilomilast
|
|
|
|
|
|
7407
|
SB-207499
|
cipemastat
|
|
|
|
|
|
6466
|
Ro 28-2653
|
clazakizumab
|
|
|
|
|
|
9195
|
ALD-518,
ALD518,
BMS-945429
|
clemastine
|
|
|
|
|
|
6063
|
HS-592,
meclastin,
Tavegil®,
Tavist®
|
clobenpropit
|
|
|
|
|
|
1223
|
VUF 9153,
VUF-9153
|
clobetasol propionate
|
|
|
|
|
|
7062
|
CCI-4725,
Clobex®,
Dermovate®,
GR 2/925,
Temovate®
|
clobetasone
|
|
|
|
|
|
9088
|
Eumovate®
|
clodronic acid
|
|
|
|
|
|
9605
|
Bonefos®,
Clasteon ®,
clodronate,
Loron®
|
clofazimine
|
|
|
|
|
|
9184
|
Lamprene®
|
clopidogrel (active metabolite)
|
|
|
|
|
|
1772
|
|
CNX-774
|
|
|
|
|
|
9266
|
|
complement C3
{Sp: Human}
|
|
|
|
|
|
9414
|
|
complement C5
{Sp: Human}
|
|
|
|
|
|
8712
|
|
compound 48/80
|
|
|
|
|
|
5531
|
|
compound 12a [PMID: 29031075]
|
|
|
|
|
|
9684
|
|
compound 18c [PMID: 25901531]
|
|
|
|
|
|
9227
|
|
compound 8c [PMID: 28760529]
|
|
|
|
|
|
9671
|
|
compound 17d [PMID: 23099093]
|
|
|
|
|
|
8196
|
|
compound 5e [PMID: 28580438]
|
|
|
|
|
|
9712
|
|
compound 7f [PMID: 29191554]
|
|
|
|
|
|
9794
|
example 32 [WO2011078413]
|
compound 7f [PMID: 29283260]
|
|
|
|
|
|
9780
|
|
compound 2g [PMID: 27390066]
|
|
|
|
|
|
9682
|
|
compound 4g [PMID: 22220592]
|
|
|
|
|
|
9236
|
Example XCII [US20160175314]
|
compound 4g [PMID: 2680437]
|
|
|
|
|
|
9198
|
|
compound 8ic [PMID: 19081254]
|
|
|
|
|
|
9478
|
CCR4 Antagonist
|
compound III [PMID: 24045148]
|
|
|
|
|
|
9709
|
|
compound II [PMID: 21329883]
|
|
|
|
|
|
9579
|
|
compound 5i [PMID: 24099220]
|
|
|
|
|
|
8223
|
GNF-PF-3777
|
compound 12p [Larson et al., 2017]
|
|
|
|
|
|
9690
|
|
compound 11 [PMID: 29442501]
|
|
|
|
|
|
9819
|
|
compound 12 [PMID: 27448772]
|
|
|
|
|
|
9453
|
|
compound 15 [PMID: 25411721]
|
|
|
|
|
|
9078
|
example 252 [WO2007110237]
|
compound 16 [PMID: 26794040]
|
|
|
|
|
|
9223
|
|
compound 1 [PMID: 24930776]
|
|
|
|
|
|
9092
|
DB36
|
compound 1 [PMID: 28611375]
|
|
|
|
|
|
9673
|
|
compound 21 [PMID: 22802221]
|
|
|
|
|
|
6918
|
C21
|
compound 21 [PMID: 24900635]
|
|
|
|
|
|
8187
|
|
compound 24 [PMID: 26987013 ]
|
|
|
|
|
|
9252
|
|
compound 25 [PMID: 28038940]
|
|
|
|
|
|
9700
|
|
compound 28 [PMID: 28671460]
|
|
|
|
|
|
9670
|
|
compound 36 [PMID: 21958547]
|
|
|
|
|
|
9391
|
|
compound 37 [PMID: 29193967]
|
|
|
|
|
|
9797
|
|
compound 3 [PMID: 28603634]
|
|
|
|
|
|
9628
|
|
compound 41 [PMID: 25000588]
|
|
|
|
|
|
9349
|
|
compound 43 [PMID: 26751273]
|
|
|
|
|
|
9492
|
|
compound 47 [PMID: 28737909]
|
|
|
|
|
|
9646
|
|
compound 6 [PMID: 25874594]
|
|
|
|
|
|
9178
|
|
compound 76 [PMID: 28657314]
|
|
|
|
|
|
9609
|
|
compound 9 [PMID: 26006010]
|
|
|
|
|
|
9761
|
|
compound 3v [PMID: 27390066]
|
|
|
|
|
|
9683
|
|
compound 1 [WO2012007375]
|
|
|
|
|
|
8084
|
|
compound 7 [WO2012007375]
|
|
|
|
|
|
8085
|
|
compstatin
|
|
|
|
|
|
9218
|
|
CORM-2
|
|
|
|
|
|
9535
|
|
corticosterone
|
|
|
|
|
|
2869
|
|
corticotropin zinc hydroxide
|
|
|
|
|
|
6967
|
|
cortisol
|
|
|
|
|
|
2868
|
Acticort®,
Plenadren®
|
CPUY192018
|
|
|
|
|
|
9710
|
compound 18e [PMID: 26258437]
|
crenolanib
|
|
|
|
|
|
7882
|
ARO-002,
CP 868596,
CP-868596
|
crisaborole
|
|
|
|
|
|
9151
|
AN 2728,
AN2728,
compound 5b [PMID: 19303290],
Eucrisa®
|
cromoglicic acid
|
|
|
|
|
|
7608
|
cromoglycate,
cromolyn,
cromolyn sodium,
FPL-670,
Intal®,
Opticrom®,
sodium cromoglicate
|
CU-CPT8m
|
|
|
|
|
|
9795
|
7-(m-Tolyl)pyrazolo[1,5-a]pyrimidine-3-carboxamide,
compound 5 [PMID: 29155428]
|
CUDC-907
|
|
|
|
|
|
8952
|
CUDC 907,
PI3K/HDAC Inhibitor centn
|
CX549
|
|
|
|
|
|
9701
|
compound 63 [WO2016048861],
CX-549
|
CXCL1
{Sp: Human}
|
|
|
|
|
|
819
|
GROα,
melanocyte growth-stimulatory activity,
MIP-2
|
CXCL10
{Sp: Human}
|
|
|
|
|
|
835
|
|
CXCL11
{Sp: Human}
|
|
|
|
|
|
836
|
IP9,
ITAC
|
CXCL12β
{Sp: Human}
|
|
|
|
|
|
845
|
SDF-1β,
stromal cell-derived factor-1 (SDF-1),
stromal cell-derived factor-1β
|
CXCL12δ
{Sp: Human}
|
|
|
|
|
|
8531
|
|
CXCL12ε
{Sp: Human}
|
|
|
|
|
|
8532
|
|
CXCL12γ
{Sp: Human}
|
|
|
|
|
|
8530
|
|
CXCL12φ
{Sp: Human}
|
|
|
|
|
|
8533
|
|
CXCL13
{Sp: Human}
|
|
|
|
|
|
3645
|
BCA-1
|
CXCL14
{Sp: Human}
|
|
|
|
|
|
3680
|
BMAC
|
CXCL16
{Sp: Human}
|
|
|
|
|
|
855
|
|
CXCL17
{Sp: Human}
|
|
|
|
|
|
6479
|
C-X-C motif chemokine 17,
dendritic cell and monocyte chemokine-like protein
|
CXCL2
{Sp: Human}
|
|
|
|
|
|
827
|
GROβ,
MIP-2α
|
CXCL3
{Sp: Human}
|
|
|
|
|
|
828
|
GROγ,
MIP-2β
|
CXCL4
{Sp: Human}
|
|
|
|
|
|
3685
|
platelet factor 4 (PF4)
|
CXCL5
{Sp: Human}
|
|
|
|
|
|
829
|
ENA-78
|
CXCL6
{Sp: Human}
|
|
|
|
|
|
820
|
|
CXCL7
{Sp: Human}
|
|
|
|
|
|
830
|
PPBP
|
CXCL8
{Sp: Human}
|
|
|
|
|
|
821
|
interleukin-8
|
CXCL9
{Sp: Human}
|
|
|
|
|
|
837
|
MIG,
monokine induced by gamma-interferon
|
CX3CL1
{Sp: Human}
|
|
|
|
|
|
856
|
fractalkine,
neurotactin
|
CXCL1
{Sp: Mouse}
|
|
|
|
|
|
4423
|
|
CXCL10
{Sp: Mouse}
|
|
|
|
|
|
4430
|
|
CXCL11
{Sp: Mouse}
|
|
|
|
|
|
4432
|
|
CXCL12
{Sp: Mouse}
|
|
|
|
|
|
4465
|
|
CXCL13
{Sp: Mouse}
|
|
|
|
|
|
4466
|
|
CXCL15
{Sp: Mouse}
|
|
|
|
|
|
3862
|
lungkine (mouse)
|
CXCL16
{Sp: Mouse}
|
|
|
|
|
|
4433
|
|
CXCL2
{Sp: Mouse}
|
|
|
|
|
|
4424
|
macrophage inflammatory protein 2 (MIP-2)
|
CXCL3
{Sp: Mouse}
|
|
|
|
|
|
4426
|
|
CXCL5
{Sp: Mouse}
|
|
|
|
|
|
4428
|
|
CXCL9
{Sp: Mouse}
|
|
|
|
|
|
4429
|
|
CX3CL1
{Sp: Mouse}
|
|
|
|
|
|
4468
|
|
CXCL1
{Sp: Rat}
|
|
|
|
|
|
826
|
CINC,
GROα,
macrophage inflammatory protein-2
|
CXCL10
{Sp: Rat}
|
|
|
|
|
|
4431
|
|
CXCL16
{Sp: Rat}
|
|
|
|
|
|
4467
|
|
CXCL2
{Sp: Rat}
|
|
|
|
|
|
4425
|
|
CXCL3
{Sp: Rat}
|
|
|
|
|
|
4427
|
|
CXCL5
{Sp: Rat}
|
|
|
|
|
|
4464
|
|
CX3CL1
{Sp: Rat}
|
|
|
|
|
|
4469
|
|
cyclosporin A
|
|
|
|
|
|
1024
|
ciclosporin,
cyclosporine,
cyclosporine A,
Ikervis®,
Neoral®,
Sandimmune®
|
|
D |
Back to top |
D4476
|
|
|
|
|
|
5940
|
casein kinase I inhibitor,
CK1 inhibitor,
D 4476
|
daclizumab
|
|
|
|
|
|
6880
|
L04AC01,
RO-24-7375,
Ro-247375,
Zenapax®
|
dagrocorat
|
|
|
|
|
|
9650
|
PF-00251802
|
danirixin
|
|
|
|
|
|
8500
|
GSK-1325756B,
GSK1325756,
GSK1325756B
|
darapladib
|
|
|
|
|
|
6696
|
SB 480848,
SB-480848
|
daratumumab
|
|
|
|
|
|
7395
|
3003-005,
Darzalex®,
HuMax-CD38,
JNJ-54767414
|
Darleukin
|
|
|
|
|
|
9756
|
L19-IL2,
L19IL2
|
dasatinib
|
|
|
|
|
|
5678
|
BMS 345825,
BMS 354825,
BMS 35482513,
Sprycel®
|
decernotinib
|
|
|
|
|
|
8309
|
adelatinib,
VRT-831509,
VX-509
|
dectrekumab
|
|
|
|
|
|
8714
|
QAX-576,
QAX576
|
deflazacort
|
 |